Eppendorf – Expanding the scale of bioprocessing technology with DASGIP expertise
Eppendorf and DASGIP's appearance at this year's Achema trade fair, from June 18 to 22 in Frankfurt, will provide both companies with the opportunity to display just how successful this “perfect mix” strategy can be. Only six months after the merger, the companies will present the first jointly developed products at this industry event.
“With a unified spirit of innovation, combined with our New Brunswick product line, we are now able to offer additional excellent solutions in the field of bioprocessing,” comments Eppendorf CEO Dr. Dirk Ehlers. “And the products presented here are just the beginning,” continues Dr. Matthias Arnold, member of the DASGIP Management Board and Head of Development. “The next innovations are already in the pipeline.”
We know bioprocessing – According to this joint motto Eppendorf continues to expand its share of the bioprocessing sector: with DASGIP parallel bioreactor systems, New Brunswick bioprocess technology, and innovative DASGIP control and analysis software.
About Eppendorf:
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO2 incubators, shakers, and cell manipulation systems. Associated consumables like pipette tips, test tubes, microtiter plates, and disposable bioreactors complement the instruments for highest quality workflow solutions. Eppendorf products are most broadly used in academic and commercial research laboratories, e.g., in companies from the pharmaceutical and biotechnological as well as the chemical and food industries. They are also aimed at clinical and environmental analysis laboratories, forensics, and at industrial laboratories performing process analysis, production, and quality assurance. Eppendorf was founded in Hamburg, Germany in 1945 and has about 2,600 employees worldwide. The company has subsidiaries in 23 countries and is represented in all other markets by distributors.
Additional information can be found at: http://www.eppendorf.com
Contact: Dr. Oliver Franz, Phone: +49 40 53 801 801, franz.o@eppendorf.de
About DASGIP:
DASGIP DASGIP has been an industry-leading supplier of benchtop bioreactor solutions for the biotech, pharmaceutical and chemical industries as well as academia and research institutions, since 1991. Process engineers, scientists and product developers use DASGIP Parallel Bioreactor Systems and software solutions for the cultivation of microbial, plant, animal and human cells to benefit from increased productivity, high reproducibility, and ease of scale-up. A team of more than 70 in-house experts contribute to the ongoing success of the company with a compound 5 years annual growth rate of about 25%. DASGIP is headquartered in Juelich (Germany) and has operations throughout Europe, North America and Asia. In January 2012, DASGIP was acquired by Eppendorf AG, premium manufacturers of liquid, sample and cell handling products and expert partners in life science laboratories.
Additional information is available at: http://www.dasgip.com
Contact: Claudia M. Hüther-Franken, Phone: +49 2461 980 119, c.huether@dasgip.de
Media Contact
All latest news from the category: Trade Fair News
Newest articles
You are What You Eat—Stanford Study Links Fiber to Anti-Cancer Gene Modulation
The Fiber Gap: A Growing Concern in American Diets Fiber is well known to be an important part of a healthy diet, yet less than 10% of Americans eat the minimum recommended…
Trust Your Gut—RNA-Protein Discovery for Better Immunity
HIRI researchers uncover control mechanisms of polysaccharide utilization in Bacteroides thetaiotaomicron. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) and the Julius-Maximilians-Universität (JMU) in Würzburg have identified a…
ASXL1 Mutation: The Hidden Trigger Behind Blood Cancers and Inflammation
Scientists show how a mutated gene harms red and white blood cells. LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have discovered how a mutated gene kicks off…